Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
MC-225 by MC2 Therapeutics for Uremic (Renal) Pruritus: Likelihood of Approval
MC-225 is under clinical development by MC2 Therapeutics and currently in Phase II for Uremic (Renal) Pruritus. According to GlobalData,...
Data Insights
MC-225 by MC2 Therapeutics for Vulvar Lichen Sclerosus: Likelihood of Approval
MC-225 is under clinical development by MC2 Therapeutics and currently in Phase II for Vulvar Lichen Sclerosus. According to GlobalData,...